Bisphosphonate enhances TRAIL sensitivity to human osteosarcoma cells via death receptor 5 upregulation

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL), a member of the TNF superfamily of cytokines, is one of the most promising candidates for cancer therapeutics. However, many osteosarcomas are resistant to TRAIL. Bisphosphonates are very effective in the treatment of bone proble...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Moon, Myung-Hee, Jeong, Jae-Kyo, Seo, Jae-Suk, Seol, Jae-Won, Lee, You-Jin, Xue, Meilang, Jackson, Christopher J., Park, Sang-Youel
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Korean Society for Biochemistry and Molecular Biology 2011
विषय:
Original Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3068296/
https://ncbi.nlm.nih.gov/pubmed/21297379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3858/emm.2011.43.3.016
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन